Reduced-intensity conditioning for allogeneic stem-cell transplantation (SCT) with fludarabine and intravenous busulfan is associated with improved toxicity profile and longer survival than conditioning with fludarabine and melphalan in patients with chemo-sensitive hematological malignancies

被引：0
|
作者：
Shimoni, Avichai [1 ]
Hardan, Izhar [1 ]
Rand, Avital [1 ]
Shem-Tov, Noga [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：596A / 596A
页数：1
相关论文
共 50 条
  • [41] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    R M Sobecks
    R Dean
    L A Rybicki
    J Chan
    K S Theil
    R Macklis
    S Andresen
    M Kalaycio
    B Pohlman
    C Ferraro
    K Cherni
    J Sweetenham
    E Copelan
    B J Bolwell
    Bone Marrow Transplantation, 2008, 42 : 715 - 722
  • [42] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
  • [43] Fludarabine-based reduced-intensity or reduced-toxicity conditioning may be associated with increased risk for secondary malignancies after allogeneic stem cell transplantation
    Shimoni, A.
    Tallis, E.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S52 - S53
  • [44] Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective
    Cremer, Birgit
    Sandmaier, Brenda M.
    Bethge, Wolfgang
    Lange, Thoralf
    Goede, Valentin
    Holtick, Udo
    Hallek, Michael
    Huebel, Kai
    ONKOLOGIE, 2011, 34 (12): : 710 - 715
  • [45] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Akanksha Chichra
    Lingaraj Nayak
    Rushabh Kothari
    Siddhesh Kalantri
    Avinash Bonda
    Anant Gokarn
    Sachin Punatar
    Sumeet Mirgh
    Nishant Jindal
    Bhausaheb Bagal
    Sadhana Kannan
    Libin Mathew
    Navin Khattry
    International Journal of Hematology, 2024, 119 : 71 - 79
  • [46] Allogeneic Transplantation in Elderly Patients with AML and MDS Comparing Reduced-Intensity Conditioning with FLAMSA-Busulfan versus Fludarabine/BCNU/Melphalan
    Fritsch, S.
    Engel, N.
    Hill, W.
    Prevalsek, D.
    Zoellner, A.
    Hubmann, M.
    Buecklein, V.
    Hausmann, A.
    Ledderose, G.
    Kolb, H-J
    Schmid, C.
    Hiddemann, W.
    Tischer, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S480 - S481
  • [47] Allogeneic Transplantation in Elderly Patients with AML and MDS Comparing Reduced-Intensity Conditioning with Flamsa-Busulfan Versus Fludarabine/BCNU/Melphalan
    Engel, Nicole
    Hill, Wolfgang
    Fritsch, Susanne
    Prevalsek, Dusan
    Zoellner, Anna-Katharina
    Hubmann, Max
    Buecklein, Veit
    Hausmann, Andreas
    Ledderose, Georg
    Kolb, Hans-Jochem
    Hiddemann, Wolfgang
    Tischer, Johanna
    BLOOD, 2014, 124 (21)
  • [48] Reduced-intensity conditioning stem cell transplantation with allogeneic blood fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning
    Martino, R
    Pérez-Simón, JA
    Moreno, E
    Queraltó, JM
    Caballero, D
    Mateos, M
    Sureda, A
    Cañizo, C
    Brunet, S
    Briones, J
    Vazquez, L
    Clopés, A
    San Miguel, JF
    Sierra, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (06) : 437 - 447
  • [49] Fludarabine, low-dose busulfan and antithymocyte globulin compared to fludarabine and low-dose TBI for reduced-intensity conditioning prior to allogeneic stem cell transplantation in patients with lymphoid malignancies
    Malard, F.
    Brissot, E.
    Guillaume, T.
    Chevallier, P.
    Delaunay, J.
    Ayari, S.
    Mahe, B.
    Dubruille, V.
    Blin, N.
    Gastinne, T.
    Harousseau, J. -L.
    Milpied, N.
    Le Gouill, S.
    Moreau, P.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S290 - S291
  • [50] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION USING FLUDARABINE, MELPHALAN, TOTAL BODY IRRADIATION AS REDUCED-INTENSITY CONDITIONING REGIMEN FOR MYELOID MALIGNANCIES IN A SINGLE INSTITUTION
    Anan, T. Nemoto
    Watanabe, R.
    Tomikawa, T.
    Sagawa, M.
    Tabayashi, T.
    Kimura, Y.
    Takahashi, Y.
    Tokuhira, M.
    Kizaki, M.
    HAEMATOLOGICA, 2015, 100 : 797 - 797
12345